Moreover, with clinical outcome analysis, we found that up-regulation of FTO was significantly associated with lower survival rates in patients with advanced stage of breast cancer (Fig. 1h) and patients with ER negative breast cancer (Fig. 1i). The gene discussed is FTO; the disease is breast cancer.